Paresh Shantilal Bagadia

Active Director Director DIN 01636125

DIN 01636125 First appointment Jun 2007 Primary industry Pharma

Unlock full profile Investments · shareholding · contact details

Current companies 4 active board seats

Past companies 3 historical roles

Total affiliations 7 Since Jun 2007

Shareholding value •••• Premium profile

About Paresh Shantilal Bagadia

Data last updated: 18 September 2026

Paresh Shantilal Bagadia is a Director at Nixi Laboratories Private Limited (since 2021), Managing Director at P R Pharma Source Private Limited (since 2007) and Director at Spark Alchemy Private Limited (since 2012), and holds 1 more current directorship. The companies operate in Pharma and Paper. The 4 current companies with reported revenue have a combined latest revenue of ₹159 Cr; the largest is Nixi Laboratories Private Limited at ₹80.22 Cr (FY 2025). Earlier, Paresh Shantilal Bagadia was a Designated Partner at Costcon Healthcare Llp (2016–2026) and Additional Director at Enrobage India Private Limited (2025) and 1 more.

DIN 01636125

Primary Designation Director

Industry Pharma

First Appointment 16 Jun 2007

Oldest Company Age 19 yrs

Largest company Nixi Laboratories Private Limited · ₹80.22 Cr (FY 2025)

Combined revenue ₹159 Cr across 4 companies

Current companies

Company	Designation	Appointment	Founded	Revenue	Status
Nixi Laboratories Private Limited U24100HP2016PTC001167	Director	01 Mar 2021	2016	₹80.22 Cr (FY 2025)	Active
P R Pharma Source Private Limited U52311MH2007PTC171721	Managing Director	16 Jun 2007	2007	₹56.27 Cr (FY 2025)	Active
Spark Alchemy Private Limited U24100MH2012PTC237710	Director	08 Nov 2012	2012	₹16.72 Cr (FY 2024)	Active
Apexio Pharma Private Limited U21001MH2023PTC416041	Director	26 Dec 2023	2023	₹5.47 Cr (FY 2025)	Active

Previous companies

Company	Designation	Appointment	Founded	Revenue	Status
Costcon Healthcare Llp AAH-5358	Designated Partner	04 Oct 2016	2016		Active
Enrobage India Private Limited U24296HR2020PTC089434	Additional Director	25 Mar 2025	2020	₹7.03 Cr (FY 2023)	Active
Abil Chempharma Private Limited U51397MH2002PTC137264	Director	29 Sep 2011	2002	₹795 Cr (FY 2025)	Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Paresh Shantilal Bagadia

Name	DIN	Company	Designation
Aditya Gupta	00694184	Nixi Laboratories Private Limited	Director
Gurudev Singh Raina	11026160	Nixi Laboratories Private Limited	Whole-Time Director
Harmanpreet Singh	06786919	Nixi Laboratories Private Limited	Director
Kaushik Mahendra Mehta	06415149	P R Pharma Source Private Limited , Spark Alchemy Private Limited	Additional Director
Manish Manharlal Dharod	10231252	Spark Alchemy Private Limited	Additional Director
Aarti Rohitash Maheshwari	09545278	Apexio Pharma Private Limited	Director
Chenthanmara Kp Nair	07346503	Apexio Pharma Private Limited	Director
Payal Paresh Bagadia	10439562	Apexio Pharma Private Limited	Director

Directorship timeline

Open interactive timeline →

Apexio Pharma Private Limited

Nixi Laboratories Private Limited

Spark Alchemy Private Limited

P R Pharma Source Private Limited

Premium access

Shareholding and investment profile for Paresh Shantilal Bagadia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

Company-level holdings
Filed share counts
Reported values
Quarterly changes

Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Paresh Shantilal Bagadia

Which companies is Paresh Shantilal Bagadia currently a director of?

Paresh Shantilal Bagadia currently holds 4 directorships: Nixi Laboratories Private Limited (Director, since 01 Mar 2021, revenue ₹80.22 Cr (FY 2025)); P R Pharma Source Private Limited (Managing Director, since 16 Jun 2007, revenue ₹56.27 Cr (FY 2025)); Spark Alchemy Private Limited (Director, since 08 Nov 2012, revenue ₹16.72 Cr (FY 2024)); Apexio Pharma Private Limited (Director, since 26 Dec 2023, revenue ₹5.47 Cr (FY 2025)).

When was Paresh Shantilal Bagadia first appointed as a director?

Paresh Shantilal Bagadia was first appointed on 16 Jun 2007 as Managing Director at P R Pharma Source Private Limited. The most recent appointment on record is 25 Mar 2025 at Enrobage India Private Limited.

What is the combined revenue of the companies Paresh Shantilal Bagadia is a director of?

The 4 current companies of Paresh Shantilal Bagadia that report revenue have a combined latest revenue of ₹159 Cr: Nixi Laboratories Private Limited ₹80.22 Cr (FY 2025); P R Pharma Source Private Limited ₹56.27 Cr (FY 2025); Spark Alchemy Private Limited ₹16.72 Cr (FY 2024); Apexio Pharma Private Limited ₹5.47 Cr (FY 2025).

Which companies was Paresh Shantilal Bagadia previously associated with?

Paresh Shantilal Bagadia held 3 earlier board appointments: Costcon Healthcare Llp (Designated Partner, 04 Oct 2016 to 28 Feb 2026); Enrobage India Private Limited (Additional Director, 25 Mar 2025 to 31 Mar 2025); Abil Chempharma Private Limited (Director, 29 Sep 2011 to 09 Nov 2013).

Who are the other directors of Paresh Shantilal Bagadia's companies?

The current boards of Paresh Shantilal Bagadia's companies include Aditya Gupta (Nixi Laboratories Private Limited), Gurudev Singh Raina (Nixi Laboratories Private Limited), Harmanpreet Singh (Nixi Laboratories Private Limited), Kaushik Mahendra Mehta (P R Pharma Source Private Limited), Manish Manharlal Dharod (Spark Alchemy Private Limited), Aarti Rohitash Maheshwari (Apexio Pharma Private Limited), among others.